Title | SWOT Analysis example - SWOT |
---|---|
Author | Mohamed Kalid |
Course | Case Studies in Strategic Managment |
Institution | Michigan State University |
Pages | 2 |
File Size | 74.8 KB |
File Type | |
Total Downloads | 109 |
Total Views | 207 |
SWOT...
SWOT Analysis for Medtronic
Strengths
Weaknesses
Strength that leads to a sustained competitive advantage:
1. Product callbacks can incur significant costs to
1. New leadership team that has experience in the
2. Pending litigations produce financial costs and
medical device industry and is committed to strengthening and growing the company.
poor media exposure.
the company.
3. Overdependence on matured cardiac rhythm Core Competencies:
2. Strategic acquisition of complementary businesses that grow the company’s capabilities. 3. Top management commitment to diverse product portfolio that includes seven core businesses. 4. Ability to continue Increasing international presence for sales, marketing, R&D, and manufacturing
management (CRM) and implantable cardioverter defibrillator (ICD) product proliferation.
4. Mandatory disclosure of conflict materials may increase costs in diligence of identifying sources.
5. Unplanned sterilization capacity shortages could have adverse impact to operations as this is essential in order to ship product.
5. Able to continuously streamline organization to create speed, agility and flexibility. Other capabilities:
6. Production systems are able to custom build to meet unique specifications.
External Opportunities
External Threats
1. The world’s population is aging and will require medical attention in the form of devices and hardware. Boston Scientific is in a good position to capitalize on this.
1. Health care reform in the U.S. will create mandatory health care for people who cannot afford it. This will increase the demand for medical devices and procedures, but will drive up costs and cut profitability.
2. Greater spending from BRIC countries creates new opportunities as there are more consumers with health insurance and middle class incomes.
2. Increased regulatory scrutiny will affect/increase product development and deployment costs.
3. Medical technology advances are increasing life expectancy. As people live longer, they will require more medical treatment. This is good for business.
3. Decreasing and/or absence of R&D tax credits will increase costs of bringing new products to the market.
4. Increase in development of surgical technologies. Many hospitals and clinics are replacing and/or purchasing new surgery equipment. Boston Scientific manufactures this type of equipment. 5. An industry trend is that larger companies are acquiring smaller firms to expand intellectual property, product offerings and market share. Boston Scientific has been very active in this trend and continues to do so.
4. Cardiovascular device market is highly competitive and is showing signs of market saturation. This will affect Boston Scientific as they are heavily invested in this market. 5. The world economic recovery is slow and the unemployment rate remains high. Many consumers do not have health insurance, which may drive down demand depending upon health care reform....